Skip to main content
Mijn bibliotheek
Shop
Nieuws Boeken Tijdschriften E-learning Web-tv Video Audio
Tips voor Mijn BSL
UITGEBREID ZOEKEN
Inloggen
Top
Quality of Life Research
Gepubliceerd in: Quality of Life Research 7/2011

01-09-2011

Choosing appropriate patient-reported outcomes instrument for glaucoma research: a systematic review of vision instruments

Auteurs: Jemaima Che Hamzah, Jennifer M. Burr, Craig R. Ramsay, Augusto Azuara-Blanco, Maria Prior

Gepubliceerd in: Quality of Life Research | Uitgave 7/2011

Log in om toegang te krijgen
share
DELEN

Deel dit onderdeel of sectie (kopieer de link)

  • Optie A:
    Klik op de rechtermuisknop op de link en selecteer de optie “linkadres kopiëren”
  • Optie B:
    Deel de link per e-mail
    Link delen
publish
Publiceer nu

Abstract

Purpose

To identify vision Patient-Reported Outcomes instruments relevant to glaucoma and assess their content validity.

Methods

MEDLINE, MEDLINE in Process, EMBASE and SCOPUS (to January 2009) were systematically searched. Observational studies or randomised controlled trials, published in English, reporting use of vision instruments in glaucoma studies involving adults were included. In addition, reference lists were scanned to identify additional studies describing development and/or validation to ascertain the final version of the instruments. Instruments’ content was then mapped onto a theoretical framework, the World Health Organization International Classification of Functioning, Disability and Health. Two reviewers independently evaluated studies for inclusion and quality assessed instrument content.

Results

Thirty-three instruments were identified. Instruments were categorised into thirteen vision status, two vision disability, one vision satisfaction, five glaucoma status, one glaucoma medication related to health status, five glaucoma medication side effects and six glaucoma medication satisfaction measures according to each instruments’ content. The National Eye Institute Visual Function Questionnaire-25, Impact of Vision Impairment and Treatment Satisfaction Survey-Intraocular Pressure had the highest number of positive ratings in the content validity assessment.

Conclusion

This study provides a descriptive catalogue of vision-specific PRO instruments, to inform the choice of an appropriate measure of patient-reported outcomes in a glaucoma context.
vorige artikel Health-related quality of life in adults reporting arthritis: analysis from the National Health Measurement Study
Literatuur
1.
Bradley, C. (2006). Feedback on the FDA’s February 2006 draft guidance on patient reported outcome (PRO) measures from a developer of PRO measures. Health and Quality of life outcomes, 4, 78.PubMedCrossRef
2.
Fitzpatrick, R., Davey, C., Buxton, M. J., & Jones, D. R. (1998). Evaluating patient-based outcome measures for use in clinical trials. Health Technology Assessment (Winchester, England), 2(14), i–74.PubMed
3.
Spaeth, G., Walt, J., & Keener, J. (2006). Evaluation of quality of life for patients with glaucoma. American Journal of Ophthalmology, 141, S3–S14.PubMedCrossRef
4.
Severn, P., Fraser, S., Finch, T., & May, C. (2008). Which quality of life score is best for glaucoma patients and why? BMC Ophthalmology, 8, 2.PubMedCrossRef
5.
Tripop, S., Pratheepawanit, N., Asawaphureekorn, S., Anutangkoon, W., & Inthayung, S. (2005). Health related quality of life instruments for glaucoma: A comprehensive review. Journal of the Medical Association of Thailand, 88, S155–S162.PubMed
6.
Altangerel, U., Spaeth, G. L., & Rhee, D. J. (2003). Visual function, disability, and psychological impact of glaucoma. Current opinion in ophthalmology, 14, 100–105.PubMedCrossRef
7.
Lee, B. L., & Wilson, M. R. (2000). Health-related quality of life in patients with cataract and glaucoma. Journal of Glaucoma, 9, 87–94.PubMed
8.
Bergner, M., & Rothman, M. L. (1987). Health status measures: An overview and guide for selection. Annual Review of Public Health, 8, 191–210.PubMedCrossRef
9.
WHO. (2001). World Health Organization, international classification of functioning, disability and health: ICF. Geneva: World Health Organization.
10.
Pesudovs, K., Burr, J. M., Harley, C., & Elliott, D. B. (2007). The development, assessment, and selection of Questionnaires. Optometry and Vision Science, 84(8), 663–674.PubMedCrossRef
11.
Cieza, A., Geyh, S., Chatterji, S., Kostanjsek, N., Ustün, B., & Stucki, G. (2005). ICF linking rules: An update based on lessons learned. Journal of Rehabilitation Medicine, 37(4), 212–218.PubMedCrossRef
12.
Moher, D., Liberati, A., Tetzlaff, J., Altman, D. G., & PRISMA Group. (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA statement. BMJ, 339, b2535. doi:10.​1136/​bmj.​b2535.PubMedCrossRef
13.
Mangione, C. M., Phillips, R. S., Seddon, J. M., Lawrence, M. G., Cook, E. F., Dailey, R., et al. (1992). (1992) Development of the ‘activities of daily vision scale’. A measure of visual functional status. Medical Care, 30(12), 1111–1126.PubMedCrossRef
14.
Valbuena, M., Bandeen-Roche, K., Rubin, G. S., Munoz, B., & West, S. K. (1999). Self-reported assessment of visual function in a population-based study: The SEE project. Salisbury eye evaluation. Investigative Ophthalmology Visual Science, 40(2), 280–288.PubMed
15.
Pesudovs, K., Garamendi, E., Keeves, J., & Elliott, D. (2003). The activities of daily vision scale for cataract surgery outcomes: Re-evaluating validity with rasch analysis. Investigative Ophthalmology Visual Science, 44(7), 2892–2899.PubMedCrossRef
16.
Steinberg, E. P., Tielsch, J. M., Schein, O. D., Javitt, J. C., Sharkey, P., Cassard, S. D., et al. (1994). The VF-14. An index of functional impairment in patients with cataract. Archives of Ophthalmology, 112(5), 630–638.PubMed
17.
Lamoureux, E. L., Chong, E. W., Thumboo, J., Wee, H. L., Wang, J. J., Saw, S. M., et al. (2008). Vision impairment, ocular conditions, and vision-specific function: The singapore malay eye study. Ophthalmology, 115(11), 1973–1981.PubMedCrossRef
18.
Maharajah, K. R., Tet, C. M., Yaacob, A., Tajudin, L. S., & Foster, P. J. (2008). Modified Bahasa Malaysia version of VF-14 Questionnaire: Assessing the impact of glaucoma in rural area of Malaysia. Clinical and Experimental Ophthalmology, 36(3), 222–231.PubMedCrossRef
19.
Ellwein, L. B., Fletcher, A., Negrel, A. D., & Thulasiraj, R. D. (1994). Quality of life assessment in blindness prevention interventions. International Ophthalmology, 18(5), 263–268.PubMedCrossRef
20.
Fletcher, A. E., Ellwein, L. B., Selvaraj, S., Vijaykumar, V., Rahmathullah, R., & Thulasiraj, R. D. (1997). Measurements of vision function and quality of life in patients with cataracts in Southern India. Report of instrument development. Archives of Ophthalmology, 115(6), 767–774.PubMed
21.
Yu, Q., Li, S., Chen, H., Ye, T., & Ao, J. (1996). Development of the scale of quality of life for diseases with visual impairment. Yen Ko Hsueh Pao [Eye science], 12(1), 36–39.
22.
Lundstrm, M., Fregell, G., & Sjblom, A. (1994). Vision related daily life problems in patients waiting for a cataract extraction. British Journal of Ophthalmology, 78(8), 608–611.CrossRef
23.
Lundstrm, M., Roos, P., Jensen, S., & Fregell, G. (1997). Catquest Questionnaire for use in cataract surgery care: Description, validity, and reliability. Journal of Cataract and Refractive Surgery, 23(8), 1226–1236.
24.
Lundstrm, M., Stenevi, U., Thorburn, W., & Roos, P. (1998). Catquest Questionnaire for use in cataract surgery care: Assessment of surgical outcomes. Journal of Cataract and Refractive Surgery, 24(7), 968–974.
25.
Mangione, C. M., Berry, S., Spritzer, K., Janz, N. K., Klein, R., Owsley, C., et al. (1998). Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: Results from focus groups with visually impaired persons. Archives of Ophthalmology, 116(2), 227–233.PubMed
26.
Mangione, C. M., Lee, P. P., Pitts, J., Gutierrez, P., Berry, S., & Hays, R. D. (1998). Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). NEI-VFQ field test investigators. Archives of Ophthalmology, 116(11), 1496–1504.PubMed
27.
Mangione, C. M., Lee, P. P., Gutierrez, P. R., Spritzer, K., Berry, S., Hays, R. D., et al. (2001). Development of the 25-item national eye institute visual function questionnaire. Archives of Ophthalmology, 119(7), 1050–1058.PubMed
28.
Hyman, L. G., Komaroff, E., Heijl, A., Bengtsson, B., Leske, M. C., & Early Manifest Glaucoma Trial Group. (2005). Treatment and vision-related quality of life in the early manifest glaucoma trial. Ophthalmology, 112(9), 1505–1513.PubMedCrossRef
29.
Jampel, H. D. (2001). Glaucoma patients’ assessment of their visual function and quality of life. Transactions of the American Ophthalmological Society, 99, 301–317.PubMed
30.
Jampel, H. D., Schwartz, A., Pollack, I., Abrams, D., Weiss, H., & Miller, R. (2002). Glaucoma patients assessment of their visual function and quality of life. Journal of Glaucoma, 11(2), 154–163.PubMedCrossRef
31.
Jampel, H. D., Friedman, D. S., Quigley, H., & Miller, R. (2002). Correlation of the binocular visual field with patient assessment of vision. Investigative Ophthalmology & Visual Science, 43(4), 1059–1067.
32.
Labiris, G., Katsanos, A., Fanariotis, M., Tsirouki, T., Pefkianaki, M., Chatzoulis, D., et al. (2008). Psychometric properties of the greek version of the NEI-VFQ 25. BMC Ophthalmology, 8, 4.PubMedCrossRef
33.
Globe, D. R., Wu, J., Azen, S. P., Varma, R., & Los Angeles Latino Eye Study Group. (2004). The impact of visual impairment on self, reported visual functioning in Latinos—the los angeles latino eye study. Ophthalmology, 111(6), 1141–1149.PubMedCrossRef
34.
Langelaan, M., Van Nispen, R. M. A., Knol, D. L., Moll, A. C., De Boer, M. R., Wouters, B., et al. (2007). Visual functioning questionnaire: Reevaluation of psychometric properties for a group of working-age adults. Optometry and Vision Science, 84(8), 775–784.PubMedCrossRef
35.
Magacho, L., Lima, F. E., Nery, A. C., Sagawa, A., Magacho, B., & Avila, M. P. (2004). Quality of life in glaucoma patients: Regression analysis and correlation with possible modifiers. Ophthalmic Epidemiology, 11(4), 263–270.PubMedCrossRef
36.
Nordmann, J. P., Viala, M., Sullivan, K., Arnould, B., & Berdeaux, G. (2004). Psychometric validation of the National Eye Institute Visual Function Questionnaire-25 (NEI VFQ-25) french version: In a population of patients treated for ocular hypertension and glaucoma. Pharmacoeconomics, 22(3), 197–206.PubMedCrossRef
37.
Rossi, G. C. M., Milano, G., & Tinelli, T. (2003). The Italian version of the 25-item national eye institute visual function questionnaire: Translation, validity, and reliability. Journal of Glaucoma, 12(3), 213–220.PubMedCrossRef
38.
Suzukamo, Y., Oshika, T., Yuzawa, M., Tokuda, Y., Tomidokoro, A., Oki, K., et al. (2005). Psychometric properties of the 25-item National Eye Institute Visual Function Questionnaire (NEI VFQ-25), Japanese version. Health & Quality of Life Outcomes, 3, 65.CrossRef
39.
Toprak, A. B., Eser, E., Guler, C., Baser, F. E., & Mayali, H. (2005). Cross-validation of the Turkish version of the 25-item National Eye Institute Visual Functioning Questionnaire (NEI-VFQ 25). Ophthalmic Epidemiol, 12(4), 259–269.PubMedCrossRef
40.
Keeffe, J. E., Lam, D., Cheung, A., Dinh, T., & McCarty, C. A. (1998). Impact of vision impairment on functioning. Australian and New Zealand Journal of Ophthalmology, 26, S16–S18.PubMedCrossRef
41.
Keeffe, J. E., McCarty, C. A., Hassell, J. B., & Gilbert, A. G. (1999). Description and measurement of handicap caused by vision impairment. Australian and New Zealand Journal of Ophthalmology, 27(3–4), 184–186.PubMedCrossRef
42.
Hassell, J. B., Weih, L. M., & Keeffe, J. E. (2000). A measure of handicap for low vision rehabilitation: The impact of vision impairment profile. Clinical Experimental Ophthalmology, 28(3), 156–161.PubMedCrossRef
43.
Weih, L., Hassell, J., & Keeffe, J. (2002). Assessment of the impact of vision impairment. Investigative Ophthalmology Visual Science, 43(4), 927–935.PubMed
44.
Lamoureux, E., Pallant, J., Pesudovs, K., Hassell, J., & Keeffe, J. (2006). The impact of vision impairment questionnaire: An evaluation of its measurement properties using Rasch analysis. Investigative Ophthalmology Visual Science, 47(11), 4732–4741.PubMedCrossRef
45.
Lamoureux, E. L., Pallant, J. F., Pesudovs, K., Rees, G., Hassell, J. B., & Keeffe, J. E. (2007). The impact of vision impairment questionnaire: An assessment of its domain structure using confirmatory factor analysis and Rasch analysis. Investigative Ophthalmology & Visual Science, 48(3), 1001–1006.CrossRef
46.
Lamoureux, E. L., Ferraro, J. G., Pallant, J. F., Pesudovs, K., Rees, G., & Keeffe, J. E. (2007). Are standard instruments valid for the assessment of quality of life and symptoms in glaucoma? Optometry and Vision Science, 84(8), 789–796.PubMedCrossRef
47.
Lu, D. W., Azuara-Blanco, A., Spaeth, G., Collur, S., Speicher, M. A., & Araujo, S. (1998). Visual limitations assessment in patients with glaucoma. British Journal of Ophthalmology, 82(11), 1347.PubMedCrossRef
48.
Turano, K. A., Geruschat, D. R., Stahl, J. W., & Massof, R. W. (1999). Perceived visual ability for independent mobility in persons with retinitis pigmentosa. Investigative Ophthalmology Visual Science, 40(5), 865–877.PubMed
49.
Turano, K. A., Massof, R. W., & Quigley, H. A. (2002). A self-assessment instrument designed for measuring independent mobility in RP patients: Generalizability to glaucoma patients. Investigative Ophthalmology Visual Science, 43(9), 2874–2881.PubMed
50.
Wolffsohn, J. S., & Cochrane, A. L. (2000). Design of the low vision quality-of-life questionnaire (LVQOL) and measuring the outcome of low-vision rehabilitation. American Journal of Ophthalmology, 130(6), 793–802.PubMedCrossRef
51.
Schiffman, R. M., Christianson, M. D., Jacobsen, G., Hirsch, J. D., & Reis, B. L. (2000). Reliability and validity of the ocular surface disease index. Archives of Ophthalmology, 118(5), 615–621.PubMed
52.
Leung, E. W., Medeiros, F. A., & Weinreb, R. N. (2008). Prevalence of ocular surface disease in glaucoma patients. Journal of Glaucoma, 17(5), 350–355.PubMedCrossRef
53.
Sumi, I., Matsumoto, S., Okajima, O., & Shirato, S. (2000). The relationship between visual disability and visual scores in patients with retinitis pigmentosa. Japanese Journal of Ophthalmology, 44(1), 82–87.PubMedCrossRef
54.
Sumi, I., Shirato, S., Matsumoto, S., & Araie, M. (2003). The relationship between visual disability and visual field in patients with glaucoma. Ophthalmology, 110(2), 332–339.PubMedCrossRef
55.
Gupta, S. K., Viswanath, K., Thulasiraj, R. D., Murthy, G. V., Lamping, D. L., Smith, S. C., et al. (2005). The development of the indian vision function questionnaire: Field testing and psychometric evaluation. British Journal of Ophthalmology, 89(5), 621–627.PubMedCrossRef
56.
Murthy, G. V. S., Gupta, S. K., Thulasiraj, R. D., Viswanath, K., Donoghue, E. M., & Fletcher, A. E. (2005). The development of the indian vision function questionnaire: Questionnaire content. British Journal of Ophthalmology, 89(4), 498–503.PubMedCrossRef
57.
Ross, J. E., Bron, A. J., & Clarke, D. D. (1984). Contrast sensitivity and visual disability in chronic simple glaucoma. British Journal of Ophthalmology, 68(11), 821–827.PubMedCrossRef
58.
Ivers, R. Q., Mitchell, P., & Cumming, R. G. (2000). Visual function tests, eye disease and symptoms of visual disability: A population-based assessment. Clinical and Experimental Ophthalmology, 28(1), 41–47.PubMedCrossRef
59.
Carta, A., Braccio, L., Belpoliti, M., Soliani, L., Sartore, F., Gandolfi, S. A., et al. (1998). Self-assessment of the quality of vision: Association of questionnaire score with objective clinical tests. Current Eye Research, 17(5), 506–511.PubMedCrossRef
60.
Mills, R. P., & Drance, S. M. (1986). Esterman disability rating in severe glaucoma. Ophthalmology, 93(3), 371–378.PubMed
61.
Viswanathan, A. C., McNaught, A. I., Poinoosawmy, D., Fontana, L., Crabb, D. P., Fitzke, F. W., et al. (1999). Severity and stability of glaucoma: Patient perception compared with objective measurement. Archives of Ophthalmology, 117(4), 450–454.PubMed
62.
Odberg, T., Jakobsen, J. E., Hultgren, S. J., & Halseide, R. (2001). The impact of glaucoma on the quality of life of patients in Norway. I. Results from a self-administered questionnaire. Acta Ophthalmologica Scandinavica, 79(2), 116–120.PubMedCrossRef
63.
Odberg, T., Jakobsen, J. E., Hultgren, S. J., & Halseide, R. (2001). The impact of glaucoma on the quality of life of patients in Norway. II. Patient response correlated to objective data. Acta Ophthalmologica Scandinavica, 79(2), 121–124.PubMedCrossRef
64.
Bechetoille, A., Arnould, B., Bron, A., Baudouin, C., Renard, J. P., Sellem, E., et al. (2008). Measurement of health-related quality of life with glaucoma: Validation of the glau-QoL 36-item questionnaire. Acta Opthalmologica, 86(1), 71–80.CrossRef
65.
Nelson, P., Aspinall, P., & O’Brien, C. (1999). Patients perception of visual impairment in glaucoma: A pilot study. British Journal of Ophthalmology, 83(5), 546–552.PubMedCrossRef
66.
Uenishi, Y., Tsumura, H., Miki, T., & Shiraki, K. (2003). Quality of life of elderly Japanese patients with glaucoma. International Journal of Nursing Practice, 9(1), 18–25.PubMedCrossRef
67.
Barber, B. L., & Santanello, N. C. (1995). Relating spontaneous adverse experience reports to scores on a questionnaire querying tolerability. International Journal of Clinical Pharmacology and Therapeutics, 33(11), 598–604.PubMed
68.
Barber, B. L., Strahlman, E. R., Laibovitz, R., Guess, H. A., & Reines, S. A. (1997). Validation of a questionnaire for comparing the tolerability of ophthalmic medications. Ophthalmology, 104(2), 334–342.PubMed
69.
Lee, B. L., Gutierrez, P., Gordon, M., Wilson, M. R., Cioffi, G. A., Ritch, R., et al. (1998). The glaucoma symptom scale. A brief index of glaucoma-specific symptoms. Archives of Ophthalmology, 116(7), 861–866.PubMed
70.
Lee, D. A. (2000). Efficacy of brimonidine as replacement therapy in patients with open-angle glaucoma or ocular hypertension. Clinical Therapeutics, 22(1), 53–65.PubMedCrossRef
71.
Lee, D. A., & Gornbein, J. A. (2001). Effectiveness and safety of brimonidine as adjunctive therapy for patients with elevated intraocular pressure in a large, open-label community trial. Journal of Glaucoma, 10(3), 220–226.PubMedCrossRef
72.
Shibuya, T., Kashiwagi, K., & Tsukahara, S. (2003). Comparison of efficacy and tolerability between two gel-forming timolol maleate ophthalmic solutions in patients with glaucoma or ocular hypertension. Ophthalmologica, 217(1), 31–38.PubMedCrossRef
73.
Haverkamp, F., Wuensch, S., Fuchs, M., & Stewart, W. C. (2004). Intraocular pressure, safety and quality of life in glaucoma patients switching to latanoprost from adjunctive and monotherapy treatments. European Journal of Ophthalmology, 14(5), 407–415.PubMed
74.
Abelson, M. B., Netland, P. A., & Chapin, M. J. (2001). Switching patients with glaucoma or ocular hypertension from dual therapy to monotherapy: Evaluation of brimonidine as a model. Advanced Therapy, 18(6), 282–297.CrossRef
75.
Noecker, R. J., & Study Group for the Efficacy of Brimonidine in Geriatric patients. (2002). Brimonidine 0.2% as a replacement for beta blockers in geriatric patients with glaucoma. Advanced Therapy, 19(2), 91–97.CrossRef
76.
Atkinson, M., Stewart, W., Fain, J., Stewart, J., Dhawan, R., Mozaffari, E., et al. (2003). A new measure of patient satisfaction with ocular hypotensive medications: The treatment satisfaction survey for intraocular pressure (TSS-IOP). Health and Quality of Life Outcomes, 1, 67.PubMedCrossRef
77.
Day, D. G., Sharpe, E. D., Atkinson, M. J., Stewart, J. A., & Stewart, W. C. (2006). The clinical validity of the treatment satisfaction survey for intraocular pressure in ocular hypertensive and glaucoma patients. Eye, 20(5), 583–590.PubMedCrossRef
78.
Balkrishnan, R., Bond, J. B., Byerly, W. G., Camacho, F. T., & Anderson, R. T. (2003). Medication-related predictors of health-related quality of life in glaucoma patients enrolled in a medicare health maintenance organization. American Journal Geriatric Pharmacotherapy, 1(2), 75–81.CrossRef
79.
Dunker, S., Schmucker, A., Maier, H., & Latanoprost/Timolol Fixed Combination Study Group. (2007). Tolerability, quality of life, and persistency of use in patients with glaucoma who are switched to the fixed combination of latanoprost and timolol. Advanced Therapy, 24(2), 376–386.CrossRef
80.
Nordmann, J. P., Denis, P., Vigneux, M., Trudeau, E., Guillemin, I., & Berdeaux, G. (2007). Development of the conceptual framework for the eye-drop satisfaction questionnaire (EDSQ) in glaucoma using a qualitative study. BMC Health Services Research, 7, 124.PubMedCrossRef
81.
Janz, N. K., Wren, P. A., Lichter, P. R., Musch, D. C., Gillespie, B. W., & Guire, K. E. (2001). Quality of life in newly diagnosed glaucoma patients: The collaborative initial glaucoma treatment study. Ophthalmology, 108(5), 887–897.PubMedCrossRef
82.
Radloff, L. S. (1977). The CES-D scale: A self-report depression scale for research in the general population. Applied Psychological Measurement, 1(3), 385–401.CrossRef
83.
Gilson, B. S., Gilson, J. S., Bergner, M., Bobbit, R. A., Kressel, S., Pollard, W. E., et al. (1975). The sickness impact profile. Development of an outcome measure of health care. American Journal of Public Health, 65(12), 1304–1310.PubMedCrossRef
84.
Bergner, M., Bobbitt, R. A., Carter, W. B., & Gilson, B. S. (1981). The sickness impact profile: Development and final revision of a health status measure. Medical Care, 19(8), 787–805.PubMedCrossRef
85.
Sloane, M. E., Ball, K., Owsley, C., Bruni, J. R., & Roenker, D. L. (1992). The Visual Activities Questionnaire: Developing an instrument for assessing problems in everyday visual tasks. Technical digest, non invasive assessment of the visual system, Topical meeting of the Optical Society of America, January. www.​eyes.​uab.​edu/​tools/​VAQ.​pdf.​
86.
Leske, M. C., Heijl, A., Hyman, L., & Bengtsson, B. (1999). Early manifest glaucoma trial: Design and baseline data. Ophthalmology, 106(11), 2144–2153.PubMedCrossRef
87.
Gedde, S. J., Schiffman, J. C., Feuer, W. J., Parrish, R. K., 2nd, Heuer, D. K., Brandt, J. D., et al. (2005). The tube versus trabeculectomy study: Design and baseline characteristics of study patients. American Journal of Ophthalmology, 140(2), 275–287.PubMedCrossRef
88.
Frost, N. A., Sparrow, J. M., Durant, J. S., Donovan, J. L., Peters, T. J., & Brookes, S. T. (1998). Development of a questionnaire for measurement of vision-related quality of life. Ophthalmic Epidemiology, 5, 185–210.PubMedCrossRef
89.
Cieza, A., Brockow, T., Ewert, T., Amman, E., Kollerits, B., Chatterji, S., et al. (2002). Linking health-status measurements to the international classification of functioning, disability and health. Journal of Rehabilitation Medicine, 34, 205.PubMedCrossRef
Metagegevens
Titel
Choosing appropriate patient-reported outcomes instrument for glaucoma research: a systematic review of vision instruments
Auteurs
Jemaima Che Hamzah
Jennifer M. Burr
Craig R. Ramsay
Augusto Azuara-Blanco
Maria Prior
Publicatiedatum
01-09-2011
Uitgeverij
Springer Netherlands
Gepubliceerd in
Quality of Life Research / Uitgave 7/2011
Print ISSN: 0962-9343
Elektronisch ISSN: 1573-2649
DOI
https://doi.org/10.1007/s11136-010-9831-1

Andere artikelen Uitgave 7/2011

Quality of Life Research 7/2011 Naar de uitgave

OriginalPaper

The World Health Organization Quality of Life Scale Brief Version: a validation study in patients with schizophrenia

OriginalPaper

Development of a Frequent Heartburn Index

OriginalPaper

The CASP-19 as a measure of quality of life in old age: evaluation of its use in a retirement community

OriginalPaper

Health-related quality of life in adults reporting arthritis: analysis from the National Health Measurement Study

OriginalPaper

The development of two postnatal health instruments: one for mothers (M-PHI) and one for fathers (F-PHI) to measure health during the first year of parenting

OriginalPaper

Quality of life in Brazil: normative values for the Whoqol-bref in a southern general population sample